Design Principles for Engineering Ionic Liquid-Gold Nanoparticles for Therapeutic Delivery to the Brain.
Authors: Shmool TA, Martin LK, Jirkas A, Morse SV, Contini C, Elani Y, Hallett JP
Ionic liquid (IL) nanotechnology holds significant promise for designing nanoscale materials with tunable viscosity, polarity, and thermal stability for advanced therapeutic applications. However, the field currently lacks comprehensive guidelines for integrating ILs into complex therapeutic formulations. Herein, we propose the key design considerations for engineering immunoglobulin G (IgG) conjugated to gold nanoparticles (AuNPs) in the presence of choline-based ILs. By judicious IL cation and anion selection, we fine-tune the supramolecular assemblies and leverage the unique physicochemical properties of ILs to impart AuNPs with advantageous characteristics including enhanced structural, thermal, and thermodynamic stabilities, highly tunable morphologies, and markedly reduced aggregation propensities. Through systematic circular dichroism measurements, the thermodynamic parameters of the complex formulations were determined, offering insight into the IgG conformational changes and design parameters for systems of enhanced IgG conjugation to AuNP surfaces. In demonstrating the power of our design approach, the complex formulation of IgG-choline chloride-AuNPs, also including trehalose, histidine, and arginine, was delivered via focused ultrasound and microbubbles across the blood-brain barrier and showed a 7.6-fold increase in delivery <i>in vivo</i> compared to the traditional formulation. We demonstrate that IgG-IL-AuNPs can be easily and precisely manipulated at the nanometer scale, enabling the formation of versatile structural configurations. Holistically, we believe the rational design approach developed will advance the engineering of tailored IL-nanocarriers for targeted therapeutic delivery and broaden the scope of IL applications in biomedicine.
Introduction
Purpose
Drug delivery with BBB opening
Study Objective
To develop a thermodynamic-guided design strategy for engineering choline-based ionic liquid–stabilized IgG–gold nanoparticle formulations that reduce aggregation and enhance stability and focused ultrasound–mediated delivery across the blood–brain barrier.
Animal model / Human subject
Mus musculus (mouse), C57BL/6, 10–13 weeks old, female
Targeted brain region(s)
Hippocampus
Cargo name and characteristics
IgG-FITC conjugated gold nanoparticles
Route of administration
intravenous (focused ultrasound-mediated blood–brain barrier delivery)
Outcomes and Safety
Summary of Outcomes
Focused ultrasound with microbubbles delivered IgG-[Cho][Cl]-AuNPs formulated with trehalose, histidine, and arginine across the blood–brain barrier in vivo, yielding ~7.6-fold higher brain delivery compared to the traditional formulation.
Safety-related matter
The paper briefly describes the ILs as "biocompatible" but does not present any safety, toxicity, or adverse-effect data; no adverse events, tissue damage, immunogenicity, or other safety assessments are reported for the formulations or the focused ultrasound delivery.
Brain Region
Ultrasound Parameters
Ultrasound instrument
Single-element focused ultrasound transducer H-198 (Sonic Concepts, Bothell, WA, USA); center frequency 1 MHz; focal depth 60.5 mm; active diameter 90 mm; central rectangular opening 30 mm × 70 mm.
FUS Frequency
1 MHz
FUS Pressure
0.530 MPa
FUS Mode
pulsed
Pulse duration
10 ms
Duration of a single FUS session
250 s
Focal Characteristics
focal depth: 60.5 mm; focal length: None; aperture size: 90 mm (active diameter; central rectangular opening 30 mm × 70 mm)
Treatment frequency
Single
We are open to feedback. If you see a mistake or have a suggestion, please contact us.
← Back to Search